Abstract 4370414: Radiomics-Based Coronary Heart Disease Classification Using Cine Cardiac MRI in a Bi-Racial Cohort

R Radhika Deshpande (Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States) Y Yi Meng K Kevin Peters (Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States) A Ahmed Fahmy (Novo Nordisk, Boston, Massachusetts, United States) L Lu Zhang E Ervin Fox (University of MS Medical Center, Jackson, Mississippi, United States) J John Carr (Vanderbilt University, Nashville, Tennessee, United States) W William Hundley (Virginia Commonwealth University, Richmond, Virginia, United States) C Christopher ODonnell (Novartis, Wellesley, Massachusetts, United States) W Warren Manning (BETH ISRAEL DEACONESS MED CTR, Boston, Massachusetts, United States) C Connie Tsao (BETH ISRAEL DEACONESS MEDICAL CTR, Boston, Massachusetts, United States)

Abstract

Introduction: Coronary heart disease (CHD) remains a leading global health burden. Cine cardiovascular magnetic resonance (CMR), the gold standard for evaluating left ventricular (LV) structure and function, avoids contrast but relies on human-derived clinical measures. Radiomics, a high-throughput image analysis method, offers a quantitative, agnostic approach to LV analysis. We hypothesized that radiomics could classify individuals with prevalent CHD in a large bi-racial cohort. Methods: bSSFP cine CMR was performed in 2,629 participants from the Framingham Heart Offspring Study (n=1277, mean age 64.5 ± 10.0 years, 53.0% female, CHD = 93) and the Jackson Heart Study (n=1352, mean age 59.1 ± 10.3 years, 62.1% female, CHD = 37) using 1.5T scanners (FHS: Philips Achieva and Siemens Espree; JHS: Philips Medical Systems HS). 130 participants had prevalent CHD, 2,499 did not. LV myocardium was segmented from 5 short-axis slices (base to apex), and 939 shape&texture radiomic features were extracted using PyRadiomics. After restricting to previously published reproducible features and principal component analysis, 92 radiomic features were retained. XGBoost with 5-fold cross-validation selected the top 5 based on mean feature importance (average gain across folds), and used in all radiomics-based models. CHD was defined as prior coronary artery disease, myocardial infarction, or unstable angina. Logistic regression models were developed to classify CHD using five configurations: (1) radiomics-only, (2) demographics only (age, sex, race), (3) demographics + LVEF (ejection fraction), and combined models: (4) demographics + radiomics, and (5) demographics + LVEF + radiomics. Model performance was compared using the DeLong test. Results: Radiomics-only models performed similarly to Demographics (AUC = 0.71 [0.66–0.76], p = 0.20) and Demographics + LVEF (AUC = 0.71 [0.67–0.76], p = 0.14), with overlapping confidence intervals and p-values for comparison ≥ 0.14 (Figure, Table), indicating no significant difference. Classification performance improved with combined radiomics, demographics, and LVEF (AUC = 0.78 [0.72–0.82], p = 0.38). Conclusion: Radiomics-only models from routine cine CMR performed comparably to models using key demographic and functional factors(LVEF) for CHD. These findings underscore that cine images alone hold valuable information about underlying disease and may enhance the discriminative ability of agnostic image interrogation in CHD classification.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (11)

R

Radhika Deshpande

Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States

Y

Yi Meng

K

Kevin Peters

Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States

A

Ahmed Fahmy

Novo Nordisk, Boston, Massachusetts, United States

L

Lu Zhang

E

Ervin Fox

University of MS Medical Center, Jackson, Mississippi, United States

J

John Carr

Vanderbilt University, Nashville, Tennessee, United States

W

William Hundley

Virginia Commonwealth University, Richmond, Virginia, United States

C

Christopher ODonnell

Novartis, Wellesley, Massachusetts, United States

W

Warren Manning

BETH ISRAEL DEACONESS MED CTR, Boston, Massachusetts, United States

C

Connie Tsao

BETH ISRAEL DEACONESS MEDICAL CTR, Boston, Massachusetts, United States